Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Neoplasms × Control Groups × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 7 Gynecologic 1 Genitourinary 1 Gastrointestinal 1 Breast 1

Conditions

Prostatic Neoplasms 2 Urinary Incontinence 1 Testicular Neoplasms 1 Motor Activity 1 Lung Neoplasms 1 Castration-resistant Prostate Cancer 1

Interventions

pembrolizumab 22 Docetaxel 13 Magnetic Resonance Spectroscopy 11 Specimen Handling 9 Radiotherapy 9 Nivolumab 9 Radiosurgery 8 Early Intervention, Educational 8 Gemcitabine 7 Cyclophosphamide 7 Standard of Care 6 Psychiatric Rehabilitation 6 Paclitaxel 6 sargramostim 5 atezolizumab 5 Surveys and Questionnaires 5 Methods 5 Ipilimumab 5 fludarabine 4 Educational Status 4 Carboplatin 4 motexafin gadolinium 3 X-Rays 3 Therapeutics 3 Radiation 3 Pemetrexed 3 Interviews as Topic 3 Immunoglobulin G 3 Fluorouracil 3 Etoposide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05319145 2022-04-13

PROFIT

Hospital Universitari Vall d'Hebron Research Institute

Phase NA Unknown

GenitourinaryThoracic

Lung Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡